146 related articles for article (PubMed ID: 6979828)
1. [Dynamics of immunoregulator T-lymphocytes and its importance in the chemo-immunotherapy of lymphoproliferative diseases in children].
Kadagidze ZG; Makhonova LA; Tabagari DZ; Zhogoleva IB; Maiakova SA
Vopr Onkol; 1982; 28(5):104-9. PubMed ID: 6979828
[TBL] [Abstract][Full Text] [Related]
2. Thymic hormone (THF) therapy in immunosuppressed children with lymphoproliferative neoplasia and generalized varicella.
Zaizov R; Vogel R; Cohen I; Varsano I; Shohat B; Rotter V; Trainin N
Biomedicine; 1977 Apr; 27(3):105-8. PubMed ID: 268220
[TBL] [Abstract][Full Text] [Related]
3. Thymus-independent expansion of T lymphocytes in children after allogeneic bone marrow transplantation.
Honda K; Takada H; Nagatoshi Y; Akazawa K; Ohga S; Ishii E; Okamura J; Hara T
Bone Marrow Transplant; 2000 Mar; 25(6):647-52. PubMed ID: 10734299
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
5. The role of the thymus and thymic humoral factors in immunotherapy of aplastic and proliferative diseases of the hemopoietic system.
Aleksandrowicz J; Skotnicki AB
Acta Med Pol; 1976; 17(1):1-17. PubMed ID: 769487
[No Abstract] [Full Text] [Related]
6. Correlation between the rosette test with neuraminidase-treated sheep red blood cells and acid phosphatase activity in lymphocytes from patients with lymphoproliferative disease.
Rudzka E; Hołowiecki J; Stella-Hołowiecka B; Krawczyk M
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):223-7. PubMed ID: 312634
[TBL] [Abstract][Full Text] [Related]
7. [The evaluation of peripheral blood lymphoid cells in children in remission a year after the cessation of treatment for acute lymphoblastic leukemia and non-Hodgkin's lymphoma type non-B].
Wylezoł I; Mazur B; Sońta-Jakimczyk D; Olejnik I
Wiad Lek; 1998; 51 Suppl 4():140-4. PubMed ID: 10731958
[TBL] [Abstract][Full Text] [Related]
8. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
10. [Immunologic cell markers in lymphoproliferative diseases].
Samoĭlova RS
Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
[No Abstract] [Full Text] [Related]
11. [Preliminary results of transplantation of thymus originating from patients with myasthenia gravis to patients with leukemia and those with Hodgkin's disease].
Rzepecki WM; Lukasiewicz M; Aleksandrowicz J; Szmigiel Z; Skotnicki A; Lisienicz J
Przegl Lek; 1973; 30(6):518-20. PubMed ID: 4732446
[No Abstract] [Full Text] [Related]
12. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
Talmadge JE; Reed E; Ino K; Kessinger A; Kuszynski C; Heimann D; Varney M; Jackson J; Vose JM; Bierman PJ
Bone Marrow Transplant; 1997 Jan; 19(2):161-72. PubMed ID: 9116614
[TBL] [Abstract][Full Text] [Related]
13. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
Karande AA; Gulwani B; Advani SH; Gangal SG
Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
15. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
Cohnen G; Augener W; Douglas SD; König E; Brittinger G
Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
[No Abstract] [Full Text] [Related]
16. [Data on the immunological profile of children with acute lymphoblastic leukemia treated by immunotherapy].
Esposito L; Benedetto N; Guerriero A
Pediatria (Napoli); 1980 Dec; 88(4):521-31. PubMed ID: 6974847
[No Abstract] [Full Text] [Related]
17. [The function of the T immunity system in patients with hemoblastoses undergoing polychemotherapy].
Zverkova AS; Bratus' GG
Vrach Delo; 1991 Feb; (2):39-43. PubMed ID: 2058119
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy and immunocorrection in the programmed treatment of hemoblastoses in children].
Makhonova LA
Gematol Transfuziol; 1984 Feb; 29(2):3-6. PubMed ID: 6546729
[No Abstract] [Full Text] [Related]
19. [Correlation between membrane markers and cytochemical markers in acute T-cell lymphoproliferative disorders. Comparison with other acute lymphoproliferative processes].
Larrocha Rabanal C; Fernández de Castro M; Viloria Vicente A; Jiménez Herráez MC; García Rodríguez MC; Madero Jarabo R
Sangre (Barc); 1984; 29(4-C):741-51. PubMed ID: 6334899
[No Abstract] [Full Text] [Related]
20. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
